EWTX20260220C36
EWTX Feb 20 2026 36.00 Call (EWTX260220C00036000)
option OPRA

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.